Pfizer Inc announced patient enrollment completion in the global SPIRE-2 cardiovascular outcome trial for its investigational agent bococizumab. SPIRE-2 is...
Read moreMerck and Pfizer announced the treatment of the first patient in a Phase III study of avelumab*, an investigational fully...
Read moreNovartis announced that the US FDA has granted three Breakthrough Therapy Designations for Ilaris® (canakinumab) to treat three rare types...
Read more
Guaranteed drug quality and promoted drug reliability are foundation for the success of all pharmaceuticals. Cleanliness is considered to be...
Read more• First patients enrolled in pivotal Phase II global trial evaluating BI 1482694 (HM61713) in patients with T790M mutation-positive NSCLC•...
Read moreThe biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically...
Read moreGlobal standardization has been one of the key trendsin the Japanese pharmaceutical industry over the past decade.This has been shapedby...
Read moreThe European Commission has given conditional marketing authorisation for biopharmaceutical company PTC Therapeutics' Translarna (ataluren) in the EU. Translarna is...
Read moreWith monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is...
Read moreLSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
